Dr. Agarwal's Health Care appoints Amar Agarwal executive chairman

Dr. Agarwal's Health Care Limited appointed Dr. Amar Agarwal as executive chairman and whole-time director for three years from November 1, 2026, following the effective amalgamation with Dr. Agarwal's Eye Hospital Limited. The November 5, 2026 board decision remains subject to member approval through a postal ballot.

What changed in Dr. Agarwal's Health Care board role?

Dr. Agarwal's Health Care changed Dr. Amar Agarwal's role from chairman and non-executive director to executive chairman and whole-time director. Its board approved the appointment and redesignation at a meeting held on November 5, 2026, which began at 4:45 p.m. Indian Standard Time and concluded at 5:53 p.m. Indian Standard Time.

The filing links the change to the effectiveness of the scheme of amalgamation between Dr. Agarwal's Eye Hospital Limited and Dr. Agarwal's Health Care. Dr. Amar Agarwal will therefore hold a whole-time executive position rather than his previous non-executive board position, although the November 5 announcement does not state a separate operational reason for the redesignation.

How long will Dr. Agarwal's Health Care executive chairman serve?

Dr. Agarwal's Health Care appointed Dr. Amar Agarwal for a three-year term effective from November 1, 2026. That start date is four days before the November 5 board-meeting disclosure, so the announcement records the role as having commenced before the decision was reported to the stock exchanges.

Dr. Agarwal's Health Care said the terms, conditions and remuneration of the new role will be identical to those Dr. Amar Agarwal received at Dr. Agarwal's Eye Hospital Limited. The November 5 filing does not disclose a rupee amount for his remuneration, so the pay attached to the three-year position cannot be quantified from this announcement.

Does Dr. Agarwal's Health Care need shareholder approval?

Yes, Dr. Agarwal's Health Care is seeking member consent for the appointment and redesignation through a postal ballot. The process will be convened under Section 110 of the Companies Act, 2013, and the board approved the postal-ballot notice on November 5, 2026.

Dr. Agarwal's Health Care has not yet disclosed the postal-ballot notice dispatch date, e-voting cut-off date, e-voting period or voting result. It said it would keep the stock exchanges informed of those subsequent stages, leaving shareholder approval as the next stated governance step despite the November 1, 2026 effective date.

What financial results accompanied the leadership change?

Dr. Agarwal's Health Care reported consolidated revenue from operations of Rs 1,269 crore for H1'FY27, up 28.7% year on year from Rs 986 crore in H1'FY26. Earnings before interest, tax, depreciation and amortisation, or EBITDA, rose 27.0% to Rs 362 crore, while profit after tax increased 50.1% to Rs 112 crore from Rs 75 crore.

The comparison shows revenue and EBITDA growing at broadly similar rates in H1'FY27, while profit after tax increased faster than either measure. EBITDA margin was 28.2%, compared with 28.3% in H1'FY26, while profit-after-tax margin rose to 8.7% from 7.4% over the same half-year comparison.

In Q2'FY27, Dr. Agarwal's Health Care reported revenue from operations of Rs 655 crore, up 31.4% from Rs 499 crore in Q2'FY26, and profit after tax of Rs 57 crore, up 55.8% from Rs 36 crore. India revenue was Rs 586 crore, up 31.6%, while services contributed 78.0% of quarterly revenue from operations and products contributed 22.0%.

How is Dr. Agarwal's Health Care expanding its network?

Dr. Agarwal's Health Care had 324 facilities as of September 30, 2026, after adding 39 centres during H1'FY27. The half-year additions comprised three tertiary, 31 secondary and five primary facilities, and management said the company added more surgical facilities in the first half than during all of FY26.

Dr. Agarwal's Health Care added 21 centres in Q2'FY27, consisting of one tertiary, 17 secondary and three primary facilities. It performed 95,841 surgeries in the quarter, up 22.2% year on year, while H1'FY27 surgeries rose 18.8% to 186,923 and same-store sales growth was 17.7% for facilities established or acquired up to H1'FY24.

What is Dr. Agarwal's Health Care planning for specialised eye care?

Dr. Agarwal's Health Care has opened a dedicated Pinhole Pupilloplasty, or PPP, centre at its Chennai flagship facility. Management said on November 5, 2026 that it intends to extend PPP across the network and globally, which stood at 324 facilities as of September 30, 2026.

During H1'FY27, Dr. Agarwal's Health Care served more than 18.4 lakh patients, a 28.5% increase, supported by more than 1,100 doctors. Management also said high-end surgeries represented about 30% of cataract volumes, while services, including surgeries, consultations, treatments and investigations, accounted for 77.9% of half-year revenue from operations.

Conclusion

The November 5, 2026 filing combines a change in board responsibilities with reported operating growth. Dr. Amar Agarwal moved from a non-executive chair role to a three-year executive chairman and whole-time director position after the amalgamation became effective, while Dr. Agarwal's Health Care reported H1'FY27 revenue of Rs 1,269 crore and profit after tax of Rs 112 crore.

The next disclosed governance event is the postal ballot, for which Dr. Agarwal's Health Care has yet to announce the notice dispatch, e-voting cut-off and voting dates. Operationally, management's stated plans are to extend PPP from the Chennai centre across its network and globally, following the addition of 39 facilities in H1'FY27.